Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leverger

Showing results (271-280 of 434) with videos related to

Pageof 44
Sort By:
British Journal of Haematology|September 22, 2016
Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panelOussama Abla, Matthew A Kutny, Anna Maria Testi, et al.
Blood|November 10, 1998
CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric OncologyL Brugières, M C Deley, H Pacquement, et al.
Blood|February 21, 2009
C/EBPA methylation is common in T-ALL but not in M0 AMLLouis Terriou, Raouf Ben Abdelali, Christophe Roumier, et al.
Blood|January 7, 2021
Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in childrenMarie Nolla, Nathalie Aladjidi, Thierry Leblanc, et al.
British Journal of Haematology|August 29, 1998
Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study groupJ Donadieu, M F Auclerc, A Baruchel, et al.
The Lancet. Haematology|October 11, 2016
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathyBérangère S Joly, Alain Stepanian, Thierry Leblanc, et al.
Bone Marrow Transplantation|February 1, 1996
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, G Leverger, T Leblanc, et al.
Pediatric Blood & Cancer|July 28, 2017
Reliable assessment of the incidence of childhood autoimmune hemolytic anemiaNathalie Aladjidi, Marthe-Aline Jutand, Cyrielle Beaubois, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2011
Contribution of HLA-A/B/C/DRB1/DQB1 common haplotypes to donor search outcome in unrelated hematopoietic stem cell transplantationBéatrice Pédron, Valérie Guérin-El Khourouj, Jean-Hugues Dalle, et al.
Pediatric Hematology and Oncology|January 6, 2018
Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trialAnne-Charlotte Teyssier, Hélène Lapillonne, Marlene Pasquet, et al.
Pageof 44

Showing results (271-280 of 434) with videos related to

Sort By:
Pageof 44
British Journal of Haematology|September 22, 2016
Management of relapsed and refractory childhood acute promyelocytic leukaemia: recommendations from an international expert panelOussama Abla, Matthew A Kutny, Anna Maria Testi, et al.
Blood|November 10, 1998
CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric OncologyL Brugières, M C Deley, H Pacquement, et al.
Blood|February 21, 2009
C/EBPA methylation is common in T-ALL but not in M0 AMLLouis Terriou, Raouf Ben Abdelali, Christophe Roumier, et al.
Blood|January 7, 2021
Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in childrenMarie Nolla, Nathalie Aladjidi, Thierry Leblanc, et al.
British Journal of Haematology|August 29, 1998
Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study groupJ Donadieu, M F Auclerc, A Baruchel, et al.
The Lancet. Haematology|October 11, 2016
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathyBérangère S Joly, Alain Stepanian, Thierry Leblanc, et al.
Bone Marrow Transplantation|February 1, 1996
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, G Leverger, T Leblanc, et al.
Pediatric Blood & Cancer|July 28, 2017
Reliable assessment of the incidence of childhood autoimmune hemolytic anemiaNathalie Aladjidi, Marthe-Aline Jutand, Cyrielle Beaubois, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2011
Contribution of HLA-A/B/C/DRB1/DQB1 common haplotypes to donor search outcome in unrelated hematopoietic stem cell transplantationBéatrice Pédron, Valérie Guérin-El Khourouj, Jean-Hugues Dalle, et al.
Pediatric Hematology and Oncology|January 6, 2018
Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trialAnne-Charlotte Teyssier, Hélène Lapillonne, Marlene Pasquet, et al.
Pageof 44